Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA4 | P22748 | 3/20 | 0.50 |
| ▸ | CA6 | P23280 | 3/20 | 0.50 |
| ▸ | CA5A | P35218 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.50 |
| ▸ | F13A1 | P00488 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | THPO | P40225 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL5133358 | 0.83 | — | — | |
| SCHEMBL117478 | 0.83 | CA12 (0.62) | CA12CA2CA4CA6CA5A | |
| SCHEMBL6723786 | 0.83 | CA12 (0.55) | CA12CA2CA4CA6CA5A | |
| SCHEMBL18316003 | 0.81 | CASP2 (0.59) | CA12CA2CA4CA6CA5A | |
| SCHEMBL30758023 | 0.81 | — | — | |
| Fluoride SCHEMBL9760383 | 0.79 | ALDH1A1 (0.46) | CA2THPOCA1TSHRMTOR | |
| SCHEMBL23924138 | 0.79 | CA12 (0.55) | CA12CA2CA4CA6CA5A | |
| SCHEMBL27946624 | 0.78 | CA12 (0.48) | CA12CA2CA4CA6CA5A | |
| SCHEMBL27970675 | 0.78 | GSR (0.44) | CA12CA2CA4CA6CA5A | |
| SCHEMBL30893657 | 0.78 | CA12 (0.42) | CA12CA2CA4CA6CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111187432-A | Double-network hydrogel utilizing spermidine covalent cross-linking agent and preparation method thereof | 吉林大学 | 2020-05-22 | — | — | CN | claimed |
| CN-111187432-B | Double-network hydrogel utilizing spermidine covalent cross-linking agent and preparation method thereof | 吉林大学 | 2022-08-09 | — | — | CN | disclosed |
| CN-111187432-A | Double-network hydrogel utilizing spermidine covalent cross-linking agent and preparation method thereof | 吉林大学 | 2020-05-22 | — | — | CN | disclosed |
| US-9545421-B2 | Nucleic acid delivery vehicle and uses thereof | GENERAL ELECTRIC COMPANY (US) | 2017-01-17 | — | — | US | disclosed |
| US-9125845-B2 | DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same | GENERAL ELECTRIC COMPANY (US) | 2015-09-08 | — | — | US | disclosed |
| US-20110274757-A1 | NUCLEIC ACID DELIVERY VEHICLE AND USES THEREOF | GENERAL ELECTRIC COMPANY (US) | 2011-11-10 | — | — | US | disclosed |
| US-20110274706-A1 | NUCLEIC ACID DELIVERY VEHICLE AND USES THEREOF | GENERAL ELECTRIC COMPANY (US) | 2011-11-10 | — | — | US | disclosed |
| US-20110206728-A1 | DNA VACCINES, USES FOR UNPROCESSED ROLLING CIRCLE AMPLIFICATION PRODUCT AND METHODS FOR MAKING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2011-08-25 | — | — | US | disclosed |